NASDAQ:ALXN

Alexion Pharmaceuticals News Headlines

$181.65
-0.34 (-0.19 %)
(As of 06/11/2021 12:00 AM ET)
Add
Compare
Today's Range
$181.21
$182.72
50-Day Range
$152.35
$181.99
52-Week Range
$99.91
$182.72
Volume1.31 million shs
Average Volume2.46 million shs
Market Capitalization$40.15 billion
P/E Ratio59.36
Dividend YieldN/A
Beta1.28

Alexion Pharmaceuticals (NASDAQ ALXN) News Headlines Today

SourceHeadline
Caelum and Alexion Present Additional Phase 2 Data Reinforcing Safety and Tolerability of CAEL-101 in AL Amyloidosis at the European Hematology Association Congress 2021Caelum and Alexion Present Additional Phase 2 Data Reinforcing Safety and Tolerability of CAEL-101 in AL Amyloidosis at the European Hematology Association Congress 2021
finance.yahoo.com - June 11 at 8:17 AM
Alexion Pharmaceuticals (NASDAQ:ALXN) Hits New 52-Week High at $179.37Alexion Pharmaceuticals (NASDAQ:ALXN) Hits New 52-Week High at $179.37
americanbankingnews.com - June 9 at 11:16 AM
Alexions (ALXN) PNH Drug Ultomiris Gets FDA Nod for KidsAlexion's (ALXN) PNH Drug Ultomiris Gets FDA Nod for Kids
finance.yahoo.com - June 8 at 12:49 PM
Alexion Announces FDA Approval of ULTOMIRIS® (ravulizumab-cwvz) for Children and Adolescents with Paroxysmal Nocturnal Hemoglobinuria (PNH)Alexion Announces FDA Approval of ULTOMIRIS® (ravulizumab-cwvz) for Children and Adolescents with Paroxysmal Nocturnal Hemoglobinuria (PNH)
finance.yahoo.com - June 7 at 3:01 PM
The Week Ahead In Biotech: Biogen, Alexion And Vertex FDA Decisions, Multiple Conference Presentations On The DeckThe Week Ahead In Biotech: Biogen, Alexion And Vertex FDA Decisions, Multiple Conference Presentations On The Deck
markets.businessinsider.com - June 7 at 10:00 AM
Alexion Pharmaceuticals (NASDAQ:ALXN) Sees Large Volume IncreaseAlexion Pharmaceuticals (NASDAQ:ALXN) Sees Large Volume Increase
americanbankingnews.com - June 3 at 11:54 AM
Alexion Pharmaceuticals, Inc. Common Stock (ALXN)Alexion Pharmaceuticals, Inc. Common Stock (ALXN)
nasdaq.com - June 2 at 11:19 PM
EU to decide on Astrazenecas $39 bln Alexion deal by July 5EU to decide on Astrazeneca's $39 bln Alexion deal by July 5
msn.com - June 1 at 8:34 AM
Alexion acquisition to be examined by U.K. regulatorsAlexion acquisition to be examined by U.K. regulators
bizjournals.com - May 26 at 8:49 AM
: AstraZeneca’s $39 billion takeover of U.S.-based Alexion Pharmaceuticals examined by U.K. regulator: AstraZeneca’s $39 billion takeover of U.S.-based Alexion Pharmaceuticals examined by U.K. regulator
marketwatch.com - May 25 at 4:00 PM
UK Competition Watchdog Probes AstraZenecas $39B Alexion TakeoverUK Competition Watchdog Probes AstraZeneca's $39B Alexion Takeover
finance.yahoo.com - May 25 at 1:05 PM
Apellis (APLS) Gets a Boost With FDA Approval of PNH DrugApellis (APLS) Gets a Boost With FDA Approval of PNH Drug
nasdaq.com - May 20 at 3:02 PM
Alexion Pharmaceuticals (NASDAQ:ALXN) Hits New 52-Week High at $177.44Alexion Pharmaceuticals (NASDAQ:ALXN) Hits New 52-Week High at $177.44
americanbankingnews.com - May 20 at 10:33 AM
Is Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Trading At A 50% Discount?Is Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Trading At A 50% Discount?
finance.yahoo.com - May 19 at 8:07 AM
Apellis (APLS) Blood Disorder Drug Empaveli Gets FDA NodApellis' (APLS) Blood Disorder Drug Empaveli Gets FDA Nod
finance.yahoo.com - May 17 at 1:39 PM
Alexion Pharmaceuticals Stock Gives Every Indication Of Being Fairly ValuedAlexion Pharmaceuticals Stock Gives Every Indication Of Being Fairly Valued
uk.finance.yahoo.com - May 13 at 11:34 PM
Caelum and Alexion Announce Upcoming CAEL-101 Data Presentations at the European Hematology Association Congress 2021Caelum and Alexion Announce Upcoming CAEL-101 Data Presentations at the European Hematology Association Congress 2021
finance.yahoo.com - May 12 at 9:08 PM
Alexion Announces Upcoming Data Presentations at the 26th European Hematology Association Virtual CongressAlexion Announces Upcoming Data Presentations at the 26th European Hematology Association Virtual Congress
finance.yahoo.com - May 12 at 4:07 PM
Alexion Pharma Shareholders Approve Acquisition By AstraZenecaAlexion Pharma Shareholders Approve Acquisition By AstraZeneca
markets.businessinsider.com - May 11 at 1:18 PM
Alexion Pharmaceuticals (ALXN) Beats Q1 Earnings and Revenue EstimatesAlexion Pharmaceuticals (ALXN) Beats Q1 Earnings and Revenue Estimates
finance.yahoo.com - April 30 at 5:39 PM
Recap: Alexion Pharmaceuticals Q1 EarningsRecap: Alexion Pharmaceuticals Q1 Earnings
benzinga.com - April 30 at 12:38 PM
Alexion (ALXN) Tops Q1 Earnings, Merger With AstraZeneca On TrackAlexion (ALXN) Tops Q1 Earnings, Merger With AstraZeneca On Track
finance.yahoo.com - April 30 at 12:38 PM
Earnings Outlook For Alexion PharmaceuticalsEarnings Outlook For Alexion Pharmaceuticals
benzinga.com - April 29 at 4:06 PM
UPDATED Alexion to Report First Quarter 2021 Results on Friday, April 30, 2021UPDATED Alexion to Report First Quarter 2021 Results on Friday, April 30, 2021
finance.yahoo.com - April 28 at 6:52 PM
Analysts Estimate Alexion Pharmaceuticals (ALXN) to Report a Decline in Earnings: What to Look Out forAnalysts Estimate Alexion Pharmaceuticals (ALXN) to Report a Decline in Earnings: What to Look Out for
finance.yahoo.com - April 26 at 5:49 PM
Were Hedge Funds Right About Piling Into Alexion (ALXN)?Were Hedge Funds Right About Piling Into Alexion (ALXN)?
finance.yahoo.com - April 22 at 2:02 PM
Alexion Pharmaceuticals (ALXN) is Overbought: Is A Drop Coming?Alexion Pharmaceuticals (ALXN) is Overbought: Is A Drop Coming?
finance.yahoo.com - April 21 at 9:19 AM
Alexion Pharmaceuticals Reaches Analyst Target PriceAlexion Pharmaceuticals Reaches Analyst Target Price
nasdaq.com - April 20 at 8:55 AM
Alexion to Report First Quarter 2021 Results on Monday, May 3, 2021Alexion to Report First Quarter 2021 Results on Monday, May 3, 2021
finance.yahoo.com - April 20 at 8:55 AM
SHAREHOLDER ALERT: Halper Sadeh LLP Investigates CNBKA, WRI, ALXN, AEGN; Shareholders are Encouraged to Contact the FirmSHAREHOLDER ALERT: Halper Sadeh LLP Investigates CNBKA, WRI, ALXN, AEGN; Shareholders are Encouraged to Contact the Firm
finance.yahoo.com - April 19 at 5:23 PM
Alexion (ALXN) Moves 3.9% Higher: Will This Strength Last?Alexion (ALXN) Moves 3.9% Higher: Will This Strength Last?
finance.yahoo.com - April 19 at 12:23 PM
AstraZeneca (AZN) Gets FTC Clearance for Alexion AcquisitionAstraZeneca (AZN) Gets FTC Clearance for Alexion Acquisition
finance.yahoo.com - April 19 at 12:23 PM
Nasdaq 100 Movers: SPLK, ALXNNasdaq 100 Movers: SPLK, ALXN
marketwatch.com - April 18 at 9:11 PM
Thinking about buying stock in Iovance Biotherapeutics, Agile Therapeutics, Wipro, TG Therapeutics, or Alexion Pharmaceuticals?Thinking about buying stock in Iovance Biotherapeutics, Agile Therapeutics, Wipro, TG Therapeutics, or Alexion Pharmaceuticals?
benzinga.com - April 18 at 6:09 AM
AstraZeneca Cleared by FTC to Acquire AlexionAstraZeneca Cleared by FTC to Acquire Alexion
thestreet.com - April 16 at 3:05 PM
AstraZeneca Receives U.S. FTC Clearance For Proposed Acquisition Of Alexion PharmaAstraZeneca Receives U.S. FTC Clearance For Proposed Acquisition Of Alexion Pharma
nasdaq.com - April 16 at 10:05 AM
Dow Jones Today Sets Pace, Stocks Open Mixed; Caterpillars New Buy Point; Progygny, Lattice Semi To Join S&P 400Dow Jones Today Sets Pace, Stocks Open Mixed; Caterpillar's New Buy Point; Progygny, Lattice Semi To Join S&P 400
finance.yahoo.com - April 16 at 10:05 AM
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Not Flying Under The RadarAlexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Not Flying Under The Radar
nasdaq.com - April 12 at 11:11 PM
These 4 Measures Indicate That Alexion Pharmaceuticals (NASDAQ:ALXN) Is Using Debt SafelyThese 4 Measures Indicate That Alexion Pharmaceuticals (NASDAQ:ALXN) Is Using Debt Safely
finance.yahoo.com - April 12 at 8:03 AM
3 Buy the Dip Stocks for a Q2 Rebound3 Buy the Dip Stocks for a Q2 Rebound
stocknews.com - April 8 at 1:44 PM
SHAREHOLDER ALERT: WeissLaw LLP Reminds CATM, KTYB, ALXN and BFTL Shareholders About Its Ongoing InvestigationsSHAREHOLDER ALERT: WeissLaw LLP Reminds CATM, KTYB, ALXN and BFTL Shareholders About Its Ongoing Investigations
finance.yahoo.com - April 5 at 11:46 PM
Alexion Pharmaceuticals Stock Appears To Be Fairly ValuedAlexion Pharmaceuticals Stock Appears To Be Fairly Valued
finance.yahoo.com - April 4 at 7:15 PM
Alexion Pharmaceuticals IncAlexion Pharmaceuticals Inc
bloomberg.com - March 26 at 7:32 PM
SHAREHOLDER ALERT: WeissLaw LLP Reminds ENBL, ALXN, KTYB, and MDCA Shareholders About Its Ongoing InvestigationsSHAREHOLDER ALERT: WeissLaw LLP Reminds ENBL, ALXN, KTYB, and MDCA Shareholders About Its Ongoing Investigations
finance.yahoo.com - March 26 at 2:31 PM
Is Alexion (ALXN) Stock A Buy Or Sell?Is Alexion (ALXN) Stock A Buy Or Sell?
finance.yahoo.com - March 20 at 1:54 PM
ALXN May 2021 85.000 putALXN May 2021 85.000 put
ca.finance.yahoo.com - March 19 at 2:00 PM
ALXN May 2021 65.000 callALXN May 2021 65.000 call
ca.finance.yahoo.com - March 19 at 8:59 AM
AstraZeneca Pops On Alexion Buyout Despite Mounting Covid Vaccine DoubtAstraZeneca Pops On Alexion Buyout Despite Mounting Covid Vaccine Doubt
finance.yahoo.com - March 16 at 3:06 PM
Why Is Alexion (ALXN) Down 3.5% Since Last Earnings Report?Why Is Alexion (ALXN) Down 3.5% Since Last Earnings Report?
finance.yahoo.com - March 6 at 1:53 PM
Alexion Announces Upcoming Data Presentations at the 73rd Annual Meeting of the American Academy of NeurologyAlexion Announces Upcoming Data Presentations at the 73rd Annual Meeting of the American Academy of Neurology
finance.yahoo.com - March 4 at 6:44 PM
This page was last updated on 6/12/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.